Evaluation of Single Dosing With Two F/TAF Tablets Among Healthy Volunteers
NCT07349758
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
24
Enrollment
OTHER
Sponsor class
Conditions
Healthy Volunteer
HIV Prevention
Interventions
DRUG:
tenofovir alafenamide [TAF] 50 mg/emtricitabine [FTC] 400mg
Sponsor
Johns Hopkins University
Collaborators
[object Object]